Drug Type Bispecific antibody |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization SparX Therapeutics, Inc.Startup |
Active Organization SparX Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | US | SparX Therapeutics, Inc.Startup | - |
Stomach Cancer | Preclinical | US | SparX Therapeutics, Inc.Startup | - |